Revelation Partners — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Aspen Neuroscienceaspenneuroscience.com in 𝕏May 2022

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.

BiotechDeep TechDigital HealthMedical DevicesSan Diego, US

Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)inDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)

Co-investorsARCH Venture Partners Lifeforce Capital OrbiMed Domain Associates EDB Investments Section 32 +10 more

IntelyCare, Inc.intelycare.com in 𝕏Apr 2022 · $115M

IntelyCare operates a healthcare talent marketplace that connects nurses with care settings including hospitals, clinics, and other healthcare facilities.

B2B MarketplacesFuture of WorkHealthtechHR TechQuincy, US

Ike Nnah(Executive Officer, Director)inDavid Coppins(Executive Officer, Director)inPrince Nnah(Director)

Co-investorsEastward Capital Partners Endeavour Vision Equitage Ventures, L.L.C.First Trust Capital Partners Generator Ventures Kaiser Permanente Ventures +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.